Real World Impact: Current Use and Outcomes These medications are no longer niche, they're influencing population level trends: Rapid Growth in Use In the U.S., reported use of GLP-1 weight loss drugs has more than doubled in the past year, from about 5.8% of adults in early 2024 to over 12% in 2025 Women tend to use these medications at higher rates than men, with 15.2% vs
Some individuals report benefits within the first few weeks, while others require 8-12 weeks to notice substantial improvements
I dont know what the future will be, but I can tell you, these drugs are here to stay, he adds
By reducing inflammation, Liraglutide protects the neuron from inflammatory damage and stimulates neural cell and stem cell proliferation (22), as well as neurite outgrowth, which is important for synaptic functions that play a key role in improving memory in neurodegenerative diseases like Alzheimers Disease (AD) and Parkinsons Disease (PD)